Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis
Roberto Di Marco(University of Catania), Tomas Olsson(Karolinska University Hospital), Ellen Iacobaeus(Karolinska University Hospital), Ruben Papoian, Antonio Salvaggio(Istituto Zooprofilattico Sperimentale Della Sicilia), Erik Wallström(Novartis (Switzerland)), S. Caracappà(Istituto Zooprofilattico Sperimentale Della Sicilia), Ferdinando Nicoletti(University of Catania), Mohsen Khademi(Karolinska University Hospital)
Cited by 31
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508